Mps VII
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) (NCT04532047) | University of California, San Francisco | 2021-07-01 |
| Mucopolysaccharidosis VII Disease Monitoring Program (NCT03604835) | Ultragenyx Pharmaceutical Inc | 2018-01-29 |
| A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) (NCT02432144) | Ultragenyx Pharmaceutical Inc | 2015-11-10 |
| Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of Age (NCT02418455) | Ultragenyx Pharmaceutical Inc | 2015-07-21 |
| Expanded Access to Mepsevii (NCT03775174) | Ultragenyx Pharmaceutical Inc |
Track Mps VII automatically
Every clearance here is in the API, with alerts when new ones post.